- Home
- ENTA vs SMHI Comparison
ENTA vs SMHI Comparison
Compare ENTA & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- SMHI
- Stock Information
- Founded
- ENTA 1995
- SMHI 1989
- Country
- ENTA United States
- SMHI United States
- Employees
- ENTA N/A
- SMHI N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- SMHI Marine Transportation
- Sector
- ENTA Health Care
- SMHI Consumer Discretionary
- Exchange
- ENTA Nasdaq
- SMHI Nasdaq
- Market Cap
- ENTA 160.3M
- SMHI 139.9M
- IPO Year
- ENTA 2013
- SMHI N/A
- Fundamental
- Price
- ENTA $7.28
- SMHI $5.49
- Analyst Decision
- ENTA Buy
- SMHI
- Analyst Count
- ENTA 4
- SMHI 0
- Target Price
- ENTA $18.00
- SMHI N/A
- AVG Volume (30 Days)
- ENTA 168.6K
- SMHI 87.2K
- Earning Date
- ENTA 08-04-2025
- SMHI 07-30-2025
- Dividend Yield
- ENTA N/A
- SMHI N/A
- EPS Growth
- ENTA N/A
- SMHI N/A
- EPS
- ENTA N/A
- SMHI N/A
- Revenue
- ENTA $64,462,999.00
- SMHI $264,089,999.00
- Revenue This Year
- ENTA N/A
- SMHI N/A
- Revenue Next Year
- ENTA $0.48
- SMHI $11.59
- P/E Ratio
- ENTA N/A
- SMHI N/A
- Revenue Growth
- ENTA N/A
- SMHI N/A
- 52 Week Low
- ENTA $4.09
- SMHI $3.63
- 52 Week High
- ENTA $17.24
- SMHI $15.36
- Technical
- Relative Strength Index (RSI)
- ENTA 60.14
- SMHI 49.42
- Support Level
- ENTA $6.87
- SMHI $5.82
- Resistance Level
- ENTA $8.47
- SMHI $6.27
- Average True Range (ATR)
- ENTA 0.50
- SMHI 0.31
- MACD
- ENTA -0.03
- SMHI -0.01
- Stochastic Oscillator
- ENTA 54.44
- SMHI 25.61
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.